Hinpetch Daungsupawong & Viroj Wiwanitkit. (2024). Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment. Taylor & Francis Group.
Chicago Style (17th ed.) CitationHinpetch Daungsupawong and Viroj Wiwanitkit. Post-marketing Safety Surveillance Study of a 9-valent Human Papillomavirus Vaccine: Comment. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationHinpetch Daungsupawong and Viroj Wiwanitkit. Post-marketing Safety Surveillance Study of a 9-valent Human Papillomavirus Vaccine: Comment. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.